Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021.
Walgreens' lower forecast comes at a time when the company tackles multiple challenges, like persistently weak prescription drug demand, reported walkouts by its pharmacy staff and a shift in focus towards integrated health services.
It has also contended with weak sales of its consumer health products due to persistently high inflation.
Walgreens announced a planned cost reduction of at least $1 billion and lowered capital expenditure by about $600 million.
Excluding items, the company reported earnings of $0.67 per share for the quarter, compared to average analysts' estimate of $0.69 per share, according to LSEG data.
Persons:
Andrew Kelly, Tim Wentworth, Khushi Mandowara, Leroy Leo, Pooja Desai
Organizations:
Walgreens, Walgreens Boots Alliance, Inc, REUTERS, Thomson
Locations:
Manhattan , New York City, U.S, Bengaluru